MM+M’s Stephen Madden sits down with Christi Shaw, CEO of Kite, a Gilead Company, on the floor of the Pharma USA conference to talk about how the biotech company utilized teamwork to navigate supply and travel constraints during the COVID-19 pandemic as it ensured patients with lymphoma were able to receive its pioneering CAR-T cell therapy.